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“One never notices what has been done; one can only see what remains to be done." 
- Marie Curie.  
  
  
ABSTRACT 
Stem cell niches regulate the fine balance between self-renewal and differentiation of various 
stem cells. Although crucial hallmarks of stem cell niches, such as the mechanical signalling, 
neural inputs communicating distant cues, the proximity to blood vessels and the structural 
support by the surrounding basement membrane (BM), have been evaluated in different niches, 
little much attention has been directed to the specific composition of the BM. As a crucial 
component of the BM, laminins have shown major importance for physiological development, 
with lack of laminin α (LAMA) 1 and 5 resulting in major developmental disruptions. 
Although, the importance of laminin 521 (LN521) in the embryonic inner cell mass (ICM) 
from which pluripotent stem cells (PSCs) are derived and in tissues such as the pancreas, 
nervous and muscular system and vasculature has been established, recent mass spectrometry 
studies of decellularized adult testicular tissue have suggested the presence of LN521 as well 
as LN121 in the testis.  
Hence, we aimed to investigate the role of LN521 in stemness behaviour of human embryonic 
stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) as well as the potential 
role of LN521 and 121 in the testicular stem cell niche. 
Utilizing five human foreskin fibroblast cultured hESC lines, pluripotency after short-term 
culture on LN521, LN121 and Matrigel was evaluated. We found that LN521, not only 
supports cell adhesion and stem cell maintenance but further homogenises the pluripotency 
expression pattern between the cell lines. 
Further, by applying LN521 as a culture substrate for derivation of Klinefelter syndrome (KS) 
hiPSCs, we demonstrated the beneficial effect of LN521 on fibroblast reprogramming 
efficiency. By utilizing LN521 as culture substrate of KS derived hiPSCs we additionally 
revealed a similar X chromosome inactivation (XCI) behaviour to female cultured PSCs, 
observed by either the maintenance of XCI with one inactive X chromosome or erosion of XCI. 
Finally, testicular laminin composition was evaluated during gonadal development and its 
importance for spermatogonial stem cell maintenance evaluated. We found LAMA 5 to be 
restricted to the vasculature while LAMA 1 was the sole α laminin chain of prenatal and pre-
and peripubertal seminiferous cords and tubules. LAMA 1 was further restricted to the 
innermost basal lamina of the adult seminiferous tubules. Interestingly, LAMA 1 loss, as a 
result of inadequate culture conditions, correlated with a loss of germ cells. 
In conclusion we demonstrated the importance of LN521 in stem cell maintenance of hESCs 
and hiPSCs and revealed a correlation between germ cell maintenance and presence of LN121. 
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1 INTRODUCTION 
1.1 PLURIPOTENT STEM CELLS 
During human development cells that give rise to and maintain the body pass through different 
phases of differentiation potential. Blastomeres, which form as a result of gamete fusion, 
originate in a totipotent state in which they can give rise to all cell types of the body in addition 
to extra embryonic tissue including the placenta. As cleavage continues, blastomeres begin to 
fuse and the blastocyst starts to form, giving rise to three cell lineages: the embryonic tissue 
(epiblast) and the two extra-embryonic tissues (trophectoderm and primitive endoderm or 
hypoblast), from which the placenta and the yolk sac develop upon implantation (see Figure 1 
for post-implantation development) [1]. At this crucial step in embryonic development, the 
epiblast cells of the inner cell mass (ICM) possess pluripotent potential and may give rise to 
any cell of the human body, with the exception of extraembryonic tissue [2]. 
As development progresses, specialisation of the embryo continues, beginning with formation 
of the amniotic cavity within the epiblast leading to the formation of the amnion at the 
trophoblast side and the epiblast disc at the hypoblast side. By embryonic day 14 gastrulation 
is already initiated, leading to the formation of the three multipotent germ layers, endo-; meso- 
and ectoderm that may only give rise to the various cell precursors of their specific germ lineage 
[3]. With the progression of organogenesis and increased signalling, cell specification 
continues until most cells of the body specialize into a unipotent state that gives rise to only 
one cell type. 
Figure 1:  Human post-implantation development and primordial germ cell specification. Adapted from Shahbazi and 
Zernicka-Goetz 2018 with permission from Springer Nature. 
Although the majority of cells in adult life lose their pluripotency, one can still find various 
tissues containing multipotent adult stem cells such as haematopoietic stem cells, skeletal 
muscle stem cells, gut stem cells, epithelial stem cells and neural stem cells [4]. 
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1.1.1 Embryonic stem cells 
In order to understand development and function of the vast variety of human cells, as well as 
the development or onset of disease, a closer look at human foetal development or isolation of 
cells from inaccessible areas of the human body would be advantageous. Thus, the majority of 
scientific breakthroughs until 1981 were achieved through animal studies and isolated human 
primary cells. However, in 1981 a major discovery by Evans and Kaufman opened-up new 
possibilities for the understanding of development.  
Following the isolation and culture of mouse embryonic ICM, Evans and Kaufman observed 
that these embryonic stem cells (ESCs), were not only capable of limitless proliferation and 
self-renewal but, if kept under the right culture conditions, could also develop into cells of the 
three germ layers in vitro and even participate in the formation of an offspring when injected 
into blastocysts [5]. Following this discovery, improvement of the isolation and culture 
techniques led to the first isolation of human ESCs in 1998 by Thomson and co-workers leading 
to major breakthroughs in human developmental studies [6]. 
1.1.2 Human induced pluripotent stem cells 
The concept of reprogramming somatic cells was first described in 1962 by John Gordon who 
transferred nuclei from differentiated intestinal cells into oocytes by somatic cell nuclear 
transfer [7]. 
Nevertheless, the terminology of induced pluripotent stem cells (iPSCs) and reprogramming of 
somatic cells as we know it today was first applied in 2006 by the group of Shinya Yamanaka 
who introduced variations of 24 genes, known to play a role in pluripotency, into mouse 
somatic cells in order to achieve a conversion into a stem cell-like state [8]. Yamanaka was 
able to show that as few as four transcription factors (POU class 5 homebox 1 (POU5F1), sex 
determining region Y-box (SOX) 2, Kruppel-like factor (KLF4) and v-Myc myelocytomatosis 
avian viral oncogene homolog (C-MYC)) were enough to convert a mouse somatic cell into an 
iPSC. In 2007 the same set of reprogramming factors were employed to generate iPSCs from 
human somatic cells opening the doors to a new area of research [9]. Interestingly, subsequent 
work by Thomson using POU5F1, SOX2, Homeobox protein NANOG (NANOG) and Lin-28 
homolog A (LIN28), among others, has revealed that reprogramming of somatic cells can be 
achieved by various additional sets of factors and enhancers increasing the efficiency [10, 11]. 
The obtained hiPSCs are similar to hESCs in regard to their morphology, culture conditions, 
surface marker expression and their ability to differentiate to all three germ layers in vivo as 
well as in vitro. Nevertheless, global gene expression profiles show a subtle difference in 
microRNA and mRNA expression compared to hESCs as well as a persistence of epigenetic 
marks from their cell type of origin which continues to affect gene expression [12]. However, 
comparison of hiPSC and hESCs of isogenic origin, excluding human variations, has shown 
conflicting results. Using male lines, no significant differences in gene expression and 
methylation profiles could be observed in contrast to a study using female lines which could 
be attributed to a sex difference [13].  
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The main advantage of hiPSCs however, is the avoidance of ethical issues related to hESCs 
and their patient specificity, allowing in vitro disease modelling, personalized regenerative 
treatment and drug discovery. Nevertheless, for clinical translation to be possible, 
reprogramming must occur without any integration into the host genome and both derivation 
and maintenance must occur under xeno-free conditions. 
Traditionally the derivation of hiPSCs was achieved by the use of retroviruses integrating into 
the host genome which could cause insertional mutagenesis and residual expression of 
reprogramming factors. Thus, reprogramming with viral vectors as retrovirus or lentivirus has 
shown to cause genetic or epigenetic as well as transcriptional abnormalities ranging from 
accumulation of point mutations, dysregulation of imprinted genes, chromosomal aberrations 
and aberrant methylation patterns etc. Therefore, the maintenance of genomic integrity by the 
use of episomal vectors, Sendai viral vectors, adenoviral vectors, plasmids, mRNA, small 
molecules and proteins has gained increasing popularity in order to avoid genetic aberrations 
which are strongly associated with cancer development [14]. 
1.1.3 The primed and naïve stem cell state 
Although mESCs and hESCs both possess the ability to differentiate into any of the three germ 
layers they have to be distinguished based on their origin and capability. 
Conventional mESCs are derived from the ICM of pre-implantation blastocysts and retain a 
naïve pluripotency, characteristic for the pre-implantation ICM. They are capable of 
differentiating into all three germ layers, form chimeras after injection into blastocysts and 
retain two active X chromosomes (Xa) in female lines. In contrast, mESCs derived from the 
epiblast of the post-implantation blastocyst (EpiSCs) retain a restricted pluripotency referred 
to as primed pluripotency which, while still capable of giving rise to all three germ layers, does 
not contribute to chimera formation and demonstrate X chromosome inactivation (XCI), as 
shown by one Xa and one inactive (Xi) X chromosome. 
In contrast, human conventional ESCs derived from 6-7 day old blastocysts ICM, consisting 
of pluripotent epiblast cells, possess differing characteristics and culture requirements, having 
fibroblast growth factor (FGF) 2 and transforming growth factor beta 1 (TGFb1) instead of 
leukemia inhibitory factor (LIF) as their core signalling molecules, as compared to 
conventional mESCs. Referred to as primed hESCs, these cells are characterized by the 
expression of POU5F1, NANOG, SOX2, tumor-related antigen (TRA)- 1-81, TRA 1-60, stage-
specific embryonic antigen (SSEA) 3 and SSEA4 [15]. 
Initially this difference between mESCs and hESCs was attributed to genetic species 
differences, as both cell types are derived from pre-implantation blastocysts. However, it has 
been shown that even ESCs derived from the mouse pre-implantation blastocyst will adapt a 
primed state if not provided with the correct naïve culture conditions. Hence providing hESCs 
with the correct naïve culture conditions allows the derivation of naïve hESCs or the conversion 
of existing primed hESC lines towards a naïve state [16] as demonstrated by a more diverse set 
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of naïve pluripotency markers as well as biallelic expression of the long non-coding RNA X 
inactive-specific transcript (XIST) in female lines [17]. 
1.1.4 Pluripotent stem cell culture 
Initially hESCs derivation was performed with mitotically inactive mouse embryonic 
fibroblasts (MEF) in combination with foetal bovine serum (FBS) in order to support PSC self-
renewal. However, the exposure to xenogeneic components and a batch to batch variability 
under such culture conditions mean the generated hPSCs are unsuitable for clinical use [6]. 
Given the increasing demand for clinically translated regenerative approaches, a variety of 
culture conditions are now available for use. Animal derived feeder cells can be substituted by 
human cells, such as human foreskin fibroblasts (hFF), while knockout serum replacement 
(KSR) and FGF2 substitute FBS and are sufficient to stimulate the self-renewal of hPSCs [18, 
19]. Various matrix proteins have also been tried in order to establish feeder-free culture 
conditions. Matrigel, which is derived from mouse sarcoma extracts, is the most commonly 
used, although often presents with batch to batch variability. However, matrixes such as type 
IV collagen, vimentin, fibronectin and human recombinant laminin-521 (LN521) can be 
employed as xeno-free alternatives [20-22]. 
1.1.5 X chromosome inactivation 
XCI is a mechanism in which one of the two X chromosomes in female somatic cells is 
transcriptionally silenced to equalize the dosage of X-linked genes between males and females, 
resulting in one Xa and one Xi chromosome in females.  
Although much progress in understanding XCI was achieved in the recent years, especially by 
the use of fluorescence in-situ hybridization (FISH) and single cell RNA sequencing, the 
mechanism of human XCI is still not completely understood. Nevertheless, it has been shown 
that the main player in XCI is the long non-coding RNA XIST. Coating the entire Xi with XIST 
in cis, it contributes to the initiation and maintenance of the X chromosome silencing by nuclear 
reorganization and recruitment of histone-modification complexes [23, 24]. Further, studies 
have shown that the Xa expresses not only transcriptional regulator ATRX (ATRX) but also X 
active specific transcript (XACT), a long non-coding RNA produced by and covering the Xa 
[23]. 
Although XCI is initiated early on in embryonic development, during the transition from a 
naïve to primed pluripotency, the random inactivation of one X chromosome is not set in stone 
and comes in various forms [25]. Recent studies have shown that human pre-implantation 
embryos show biallelic expression of XIST without fully silencing the X chromosomes but 
rather dampening the net X output. In post-implantation embryos however, the XCI changes to 
a complete silencing of only one X chromosome resulting in a Xa/Xi state that is maintained 
throughout life in somatic cells.   
Nevertheless, reactivation of the Xi occurs during female germ cell development to ensure that 
each haploid germ cell contains one Xa. While the reactivation of the, during meiosis, 
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transcriptionally inactivated X chromosome in sperm cells has been demonstrated directly after 
fertilization.  
It is important to note that XCI does not silence the Xi completely. In female somatic cells 
around 10-15% of X-linked genes “escape” the silencing program and are still expressed, 
whereby expression of escape genes can vary for given genes in specific tissues explaining 
tissue-specific sex differences [26]. 
1.1.5.1 X chromosome inactivation in pluripotent stem cells 
As XCI is established early in embryonic development, PSCs represent a great source to 
investigate the molecular mechanisms involved in XCI as they recapitulate XCI in various 
phases of embryonic development. Although primed female hPSC lines initially express one 
Xa and one Xi, the XCI maintenance during culture has shown to be unstable resulting in cells 
with no XCI (Xa/Xa), XCI (Xa/Xi), or XCI with erosion of silencing marks (Xa/Xi eroded) 
[27]. The recent optimization of naïve PSC cultures has provided new insights into XCI as such 
as those cells resemble not only the pre-implantation state in terms of genes expression but also 
XCI. Naïve PSCs derived by the 5iLA and 2i method have shown biallelic XIST expression 
without complete silencing of both X chromosomes but dampening the net X output as seen in 
human pre-implantation embryonic studies [2, 17]. 
1.1.5.2 X chromosome inactivation in Klinefelter syndrome 
The Klinefelter syndrome (KS) is the most frequent sex chromosome abnormality in males 
with an incidence of 1:500 to 1:1000. It is an X chromosome aneuploidy characterized in 80-
90% of the cases by a non-mosaic 47, XXY karyotype. However, higher-grade aneuploidies 
and mosaic forms of KS account for the remaining 10-20%, making KS a clinically variable 
condition. 
The acquisition of the supernumerary X chromosome occurs due to failures in chromosome 
disjunction in anaphase of meiosis I, meiosis II or mitosis during either oogenesis, 
spermatogenesis or, occasionally, during the first cell cleavages of a fertilized oocyte [28].  
As KS patients have no obvious phenotypic distinction compared to normal healthy males and 
possess a diverse clinical phenotype (based on the grade of aneuploidy, mosaicism, structural 
abnormalities and origin of the X chromosome), the diagnosis is often made once KS patients 
seek medical attention related to fertility issues [28].  
KS patients typically present with a tall stature, mild language and speech disabilities, small 
testes, gynecomastia, sparse body hair, and hypogonadism, resulting in azoospermia with 
hyalinization and fibrosis of the seminiferous tubules [28].  
As in females, the same mechanism of XCI is observed in KS patients, with incomplete 
silencing of the Xi (resulting in the escape of 10-15% of X-linked genes), contributing to most 
of the mentioned phenotypic features [28]. 
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This is especially relevant when it comes to the reproductive life of KS patients as it is assumed 
that the escape genes not only affect the proper testicular somatic environment but also the 
meiotic progression of germ cells themselves leading to progressive germ cell depletion after 
the onset of puberty [28].  
1.2 GERM CELL DEVELOPMENT 
Germ cells are one of the most unique cell types of the human body. They not only proliferate 
and differentiate but are the only cell type capable of meiosis, resulting in haploid sperm and 
oocytes, creating, once fused with each other, a new life, passing on our genetic information to 
the next generation. 
1.2.1 Foetal germ cell development 
The first description of human germ cells dates back to 1948, when Emil Witschi observed 
primordial germ cells (PGC) in the extraembryonic yolk sac close to the allantois in embryos 
three weeks post conception (wpc) (Figure 1) [29]. Witschi was further able to observe the 
migration of PGCs from the yolk sac to the hindgut followed by the colonization of the gonadal 
ridge by PGCs from 4 until 6 wpc [30]. Many decades later however, due to the inaccessibility 
of early developmental stages, the process of human germ cell development and differentiation 
is still not fully understood. 
As a response to WNT and bone morphogenic protein (BMP) signalling from the 
extraembryonic tissue, germ cell specification is suggested to start in the posterior epiblast or 
the emerging amnion, resulting in the specification of hPGC precursors [31]. This process has 
shown to be highly dependent on the expression of SOX17, as knock-out of SOX17 prevents 
specification of hPGCs while over-expression induces hPGCs differentiation without the need 
of further external signals [31-33]. In addition to SOX17, transcription factor AP-2 gamma 
(TFAP2C) and specifically beta-interferon gene positive-regulatory domain I binding 
(BLIMP1), are essential for hPGCs specification (Figure 1), as well as the repression of the 
pluripotency gene SOX2 and upregulation of POU5F1, NANOG and maintenance of the naïve 
pluripotency gene, KLF4 [31, 33, 34] .  
On their developmental journey to the gonadal ridges through the yolk sac, allantois and hind 
gut, hPGCs undergo proliferation and nuclear reprogramming as determined by the progressive 
loss of XIST and Histone 3 lysin 27 trimethylation (H3K27me3) leading to X chromosome 
reactivation in females [30, 35]. Once settled in the gonadal ridge around 5 wpc the hPGCs, 
now called gonocytes, start colonizing the gonad and initiate genome wide DNA demethylation 
and chromatin remodelling, enabling the erasure of imprints and the establishment of sex-
specific imprints until 9 wpc [30, 32]. From 7 wpc, up until which point female and male 
embryos differ only in their allosomes, the bi-potential gonad starts its path towards testicular 
or ovarian development, initiated by signalling from the surrounding environment [30, 36].  
Male sex specification in particular, is induced around 7 wpc with the expression of sex-
determining region Y (SRY) and SOX9 [30, 37-39] in the supporting gonadal cells [40], leading 
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to the specification of Sertoli cells and formation of seminiferous cords. At this point male 
gonocytes start populating the seminiferous cords and begin to proliferate, increasing to about 
150.000 germ cells by 9 wpc [41]. Although the exact mechanisms underlying gonocyte 
proliferation are unknown, extrapolation from in vivo mouse studies and in vitro differentiation 
studies suggest that BMP4, LIF, FGF2 and epidermal growth factor (EGF) are crucial factors 
[42, 43].   
During the first trimester, male gonocytes remain mitotically active, expressing hPGC markers 
such as POU5F1, NANOG, SSEA4, Nanos homolog 3 (NANOS3), KIT proto-oncogene (c-
KIT), deleted in azoospermia like (DAZL) and DEAD-box helicase 4 (DDX4). In parallel to 
the loss of mitotic activity their expression profile changes to DDX4 and Melanoma-Associated 
Antigen A4 (MAGE-A4) until the onset of puberty, indicating a transition towards the 
spermatogonial stem cell (SSC) population. In support of this, single cell RNA sequencing of 
two and seven days old neonatal and adult human testicular tissue has revealed the presence of 
two distinct germ cell populations in the neonate, consisting of cells similar to human 
gonocytes and cells expressing pre-spermatogonia profiles [44]. 
At this point the testicular differentiation, as observed by the differentiation of the Wolffian 
ducts into the epididymis, seminal vesicles and vas deferens, and the virilisation of external 
genitalia, is independent of the pituitary axis and achieved by the androgen production of 
immature Leydig cells which are stimulated by chorionic gonadotrophin [45]. 
In contrast, oogonia specification occurs during week 9 of development and is characterised by 
a greater period of mitotic activity. Subsequent meiosis, which overlaps with mitosis, is 
initiated by retinoic acid and the expression of STRA8, around week 10-11 of development and 
results in primary oogonia which remain quiescence until the onset of puberty [41].  
1.2.2 From “mini-puberty” and puberty to spermatogenesis 
Although the hypothalamic-gonadotropin-axis is largely inactive until the onset of puberty at 
the age of 9-14 years, brief activity, referred to as mini-puberty, is observed during the first 
months of life, whereby gonotrophin-releasing hormone from the hypothalamus stimulates 
the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the 
pituitary [45, 46]. During this phase, LH stimulates the production of testosterone by 
immature Leydig cells, followed by an increase in Anti-müllerian hormone (AMH) upon 
FSH stimulation of Sertoli cells and subsequent germ cells proliferation. Following a peak of 
hormone levels at 3 months after birth, a slow decrease follows with undetectable levels by 6 
months (see Figure 2 for hormonal levels and testicular growth during male development) 
[45].  
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Figure 2: Hormone levels and testicular growth during male development. Adapted from Condorelli et al 2018 with 
permission from Springer Nature. 
At the onset of puberty, before which point the testicular size doubles from 2-4 mL in size, the 
hypothalamic-gonadotropin-axis is revived leading to a surge in LH and FSH levels [47]. In 
the pubertal testis LH stimulates the maturation of Leydig cells and induces the production of 
testosterone [48]. Testosterone in return induces the maturation of Sertoli cells seen by the loss 
in proliferative capacity, establishment of the blood-testis barrier, decrease in AMH levels and 
increase in inhibin B levels, creating a negative-feedback loop with FSH [45, 49, 50]. Further, 
testosterone stimulates the production of Glial cell derived neurotrophic factor (GDNF), FGF2, 
BMPs and retinoic acid by Sertoli and peritubular cells via their androgen receptors and thereby 
influences SSC differentiation and proliferation. 
Located at the basement membrane (BM) of seminiferous tubules, SSCs can be classified as 
either quiescent Adark spermatogonia, which representing the SSCs reserve, or mitotically 
active Apale spermatogonia, which are capable of entering meiosis to ultimately differentiate 
to elongated sperm. At this stage of maturation, they express markers such as Zinc finger 
protein PLZF (PLZF), c-KIT, MAGE-A4, DDX4 and DAZL [51]. 
Once Apale spermatogonia receive differentiating cues they give rise to type B spermatogonia, 
which will continue to mitotically divide, generating two primary spermatocytes, which leave 
the SSC niche and cross the blood-testis barrier in order to proceed with first meiotic division 
[49]. At this stage, primary spermatocytes express markers such as Boule Homolog RNA 
binding protein (BOULE), Synaptonemal complex protein 3 (SYCP3), DAZL and DDX4. The 
second meiotic division leads to the formation of round spermatids, which differentiate to 
elongated spermatids in a morphogenic process without further proliferation. At this stage 
elongated spermatids express protamine, acrosin and CAMP responsive element modulator 
(CREM) [52]. During this phase of spermatogenesis, major structural changes such as nuclear 
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condensation, histone replacement, formations of cytoplasmic droplets and flagellum 
formation occur. Lastly, immotile spermatozoa are transported into the rete testis before 
entering the epididymis for final maturation. In total the process of spermatogenesis together 
with spermiogenesis takes around 74 days in humans giving  rise to 16 spermatids from each 
single SSC [51] and a daily production of 150-275 million spermatozoa [46]. 
1.2.3 Somatic gonadal cells 
Unlike PGC that migrate into the gonadal ridge, the gonadal ridge itself is proposed to arise 
from coelomic epithelial progenitor cells proliferating on the mesonephros surface, creating a 
dense cell layer [53, 54]. Fragmentation of the underlying basement membrane then [55] allows 
the ingression of genital ridge progenitor cells that continue to proliferate giving rise to both 
steroidogenic and supporting cells [56, 57] under the influence of mainly GATA binding 
protein 4 (GATA4), Wilms Tumour 1 (WT1), Steroidogenic factor 1 (SF1) signalling [58, 59]. 
In the case of male sex determination, the supporting cells, which are the first to ingress into 
the gonad, differentiate into Sertoli cells retaining WT1 expression, while the steroidogenic 
cells which appear later, differentiate into Leydig cells retaining SF1 expression [60]. 
1.2.3.1 Sertoli cells 
The first observations of Sertoli cells date back as early as 1865, when Enrico Sertoli first 
described “cellule ramificate” [61], branched cells supporting the developing germ cells which 
were later confirmed by Von Ebner and called Sertoli cells [62]. 
The differentiation of Sertoli cells from the supporting cells and, with that, the path of male 
sex-determination, is induced by the expression of SRY gene [37-40, 63], located on the Y 
chromosome.  Its sole expression in Sertoli cells begins around 4 wpc with a peak around 5 to 
6 wpc and subsequent persistence at low levels even in the mature testis [59].  
The expression SRY stimulates the up-regulation and expression of SOX9 in supporting cells 
which, in turn, stimulates the expression of FGF9, creating a positive feedback loop with SOX9 
[36, 41, 65-67] leading to the specification of Sertoli cells and subsequent formation of 
seminiferous cords around 7 to 9 wpc. SRY has been shown to be the key regulator of male sex-
determination as mutation leads to a female sex-reversed phenotype in humans [39] as well as 
male sex reversal when introduced into XX mice [68]. 
Nevertheless, WT1, GATA4, doublesex and mab-3-related transcription factor 1 (DMRT1), 
SF1, and SOX9 are thought to play a key role in Sertoli cell specification, as exogeneous 
expression of all five factors has been shown to be sufficient for the differentiation of Sertoli-
like cells from human fibroblasts [69].  
In addition to male sex-determination, the Sertoli cell differentiation leads to subsequent 
production of AMH around 5 to 6 wpc, leading to the regression of the Müllerian ducts and 
prevent the development of female internal genitalia [46].  
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In contrasts to foetal gonad development, where global meiotic entry of germ cells is prevented 
by the degradation of retinoic acid by Cyp26B1, Sertoli cells form a tight barrier composed of 
Sertoli-to-Sertoli cell tight junctions during puberty, allowing for meiotic progression. This 
way Sertoli cells are able to create an immune-privileged blood-testis barrier, protecting and 
governing advanced meiotic germ cells in the adluminal compartment of seminiferous cords 
[47, 70] and preventing meiotic entry of basal SSCs. At this point Sertoli cells exhibit 
cytoplasmic projections showing morphological resemblance to tree branches, allowing the 
support and migration of different germ cell stages towards the seminiferous lumen [46].  
Furthermore, they play a crucial role in SSC maturation and spermatogenesis through the 
expression of transferrin, acetate, lactate, androgen-binding protein, GDNF, TGFb1 and extra 
cellular matrix (ECM) components [46]. 
1.2.3.2 Peritubular myoid cells 
In contrast to rodents, the seminiferous tubule wall in men is surrounded by a BM followed by 
acellular space and multiple layers of elongated peritubular myoid cells with contractile 
properties. Peritubular cells initiate proliferation after birth [71] building up a multi-layered 
structure surrounding the seminiferous tubules, a process which continues until the onset of 
puberty. Comparison of neonatal and adult peritubular cells has revealed distinct spatial 
separation [44] likely based on the development of smooth muscle characteristics induced by 
androgens [72] through their androgen receptor. Although the most important role of 
peritubular cells is their peristaltic action facilitating intratesticular transport of immotile 
spermatozoa to the rete testis, it has been demonstrated that they also fulfil important secretory 
functions [73]. 
Together with Sertoli cells they are responsible for the production and deposition of ECM 
proteins such as fibronectin, collagens and laminins [46, 74], establishing the seminiferous BM 
as well as the blood-testis barrier. Furthermore, it has been shown that peritubular myoid cells 
support the secretion of inhibin, transferrin and androgen-binding protein by Sertoli cells [46] 
as well as contributing to the production of GDNF, supporting the SSC renewal [75].  
1.2.3.3 Leydig cells 
Leydig cells located in the interstitium of the testes were first described in 1850 by Franz 
Leydig in various animal testes [76] and confirmed 1854 in humans by Albert Kölliker [77]. 
The differentiation of mature Leydig cells occurs in three waves [46]. In the foetus, Leydig cell 
differentiation from the steroidogenic cell population is induced around 6 to 16 wpc, as a 
downstream event of SRY expression, leading to the production of testosterone and secondary 
sexual differentiation [46, 78]. Despite LH independent initiation of Leydig cell differentiation, 
hCG/LH stimulation has shown to be required from 5 wpc for the maintenance of testosterone 
production. Following a regression of Leydig cells, the second wave occurs within the first 
months of birth and supports, besides testosterone, the production of insulin-like factor 3 
mediating testicular descent to the scrotum [46, 79]. 
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In contrast to foetal Leydig cell development, the differentiation of adult Leydig cells appears 
LH dependent, and is achieved by the LH surge which takes place at the onset of puberty, 
leading to the continuous production of testosterone.   
In addition to their steroidogenic function, Leydig cells further produce oxytocin, stimulating 
the contraction of peritubular myoid cells and transportation of spermatozoa to the rete testis 
[46]. 
1.2.4 In vitro germ cell maturation 
Infertility affects approximately 10% of the male population and can be a result of sperm-
production problems, genetic mutations, infections, medications, chemicals or further 
unknown factors [80]. Exposure to radiation and chemotherapy as part of malignant and 
haematological disease treatment can additionally have severe, and often permanent, 
gonadotoxic effects. While adult patients with progressive spermatogenesis have the option of 
sperm cryopreservation prior to gonadotoxic therapy, immature testicular tissue 
cryopreservation is the only option for childhood cancer patients, in whom spermatogenesis 
has not yet started [81]. Given the destructive effect of treatments on prepubertal SSCs and 
increasing childhood cancer survival rates, current research is being driven towards the 
development of novel fertility preservation approaches such as SSC transplantation, testicular 
tissue transplantation or in vitro germ cell maturation [82]. Although two-dimensional germ 
and Sertoli cell co-cultures have demonstrated the potential of in vitro germ cell progression 
[83], three-dimensional cultures in scaffolds or as tissue explant have shown superior support 
of cell functionalization and organization [84]. Adaptation of the rat testicular explant culture 
in an air-liquid interphase, first developed in the 1960’s, has led to the differentiation of mouse 
germ cells by Sato and colleagues in 2003 [85, 86], while promising results for steroidogenic 
functionality of human Leydig cells and maturation of human Sertoli cells have been 
demonstrated recently. Nevertheless, a common obstacle of this methods is the significant loss 
of SSCs with culture time [87-89]. 
1.3 STEM CELL NICHES 
The first concept of a specialized stem cell environment was established in 1978, by Schofield 
who suggested a specific anatomical location of niches as well as differentiation of their 
harboured stem cells upon niche removal [90, 91].  
In order to regulate the fine balance between self-renewal and differentiation, stem cells are 
controlled by intrinsic factors in response to extrinsic cues provided by their surrounding 
microenvironment, which Schofield defined as the stem cell niche [90, 91]. Although stem cell 
niches have a common function providing trophic support, delivering topographic information, 
structural support and physiological cues in order to regulate stem cell functions, they are also 
as versatile as the stem cells they support. Stem cell niches in the adult human include skeletal 
muscle stem cells found along the myofiber, gut stem cells in intestinal crypts, epithelial stem 
cells in the follicular bulge, neural stem cells in the hippocampus and the olfactory bulb, 
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haematopoietic stem cells at the endosteal surface of trabecular bone and SSCs adjacent to the 
BM of the testicular seminiferous tubules.  
Examination of the various stem cell niches has led to the identification of certain hallmarks 
such as the supporting stromal cells, which interact directly with the stem cells and each other, 
a close proximity to blood vessels, ECM proteins, which provide structural support as well as 
mechanical signals, and neural inputs, allowing the communication of distant physiological 
cues to the environment (see Figure 3 for hallmark depiction). Given the complexity of stem 
cell niches, it is no surprise that vulnerable stem cells are sensitive to deregulations in the niche, 
which can lead to pathologies related to tissue degeneration and tumorigenesis or even stem 
cell depletion [4]. 
 
Figure 3: Hallmarks of stem cell niches.  
1.3.1 Spermatogonial stem cell niche 
As mentioned before, spermatogenesis is the process of SSC differentiation through mitotic 
and meiotic cell divisions leading to the formation of haploid spermatids. SSCs, which are 
situated at the basal membrane of the seminiferous tubules, are anchored to the BM and 
surrounded by Sertoli cells forming a blood-testis barrier [92].  Once the mitotically active 
SSCs (Apale SSC) differentiate and give rise to type B spermatogonia, mitotic divisions will 
generate spermatocytes which will cross the blood-testis barrier in order to proceed with 
meiotic divisions. As the initial steps of SSC differentiation happen in a two-dimensional 
fashion it is assumed that the SSC niche must be situated at the tubular BM and comprise 
discrete areas to ensure quiescence of Adark SSCs and mitotic activity of Apale SSCs [50]. 
Various studies could so far link the SSC niche to the close proximity of blood vessels as well 
as bordering to interstitial tissue, which is surrounding the seminiferous tubules, rather than 
bordering another tubule. Although Sertoli cells are the only cell type in direct contact with 
SSCs, it is possible that the sounding interstitial cells such as Leydig cells, peritubular myoid 
cells and macrophages, determine whether Sertoli cells produce SSC self-renewing factors, 
such as FGF2 or GDNF, or differentiating factors, such as activin A, BMP4 and retinoic acid. 
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Further, it has been shown that adhesion molecules such as integrins, expressed on SSCs and 
Sertoli cells, play a major role in SSC homing to the basal membrane, however extensive 
investigations of the role of the basal membrane in the SSC niche have yet to be carried out 
[93].  
1.3.2 Basement membranes as part of the niche 
BM are self-assembling sheets of ECM approximately 200nm in diameter [94] which coat the 
basal site of epithelial and endothelial cells, as well as surrounding adipocytes, nerve axons and 
muscles, thereby compartmentalizing different cell types [95]. Their main composition is based 
on a laminin and collagen polymer network in addition to other components such as nidogen, 
perlecan and many more [96]. Nevertheless, BMs show a tissue and organ-specific molecular 
composition in order to support their specific biological function [96, 97]. They provide 
structural support and polarity for cells via the linkage of the actin cytoskeleton through 
adhesion molecules, such as intergins, to the ECM facilitating biological functions such as cell 
adhesion, migration and signalling [98, 99].  
Since 1993, when Adams and Watt demonstrated various developmental defects in response 
to modifications of ECM composition, the fundamental role of BM during development as well 
as in adult stem cell homeostasis has been recognized [100].  
BMs have been shown to modify signalling not only through direct binding of cell surface 
receptors but also indirectly via non-canonical presentation of growth factors, such as [97] 
FGF2, TGFb1, heparin epidermal growth factor (HP-EGF) and vascular endothelial growth 
factor (VEGF) [101], through which they mediate cell signalling effects [102].  
1.3.2.1 Laminin 
Laminins are one of the most abundant proteins in the BM, consisting of three laminin chains, 
a, b, g, which assemble through a coiled coil to a cross-shaped heterotrimer. So far 16 laminin 
isoforms have been found in mammals in various combinations of the five a, three b and two 
g  chains allowing cell type-specific functions such as adhesion, differentiation, migration and 
phenotype maintenance [103, 104]. 
The N-terminal region of the a chain consists of three globular domains which are separated 
by three EGF-like repeats, while the C-terminal region consists of five globules, called the G 
domain. In contrast, the N-terminal region of b and g chains consist of only two globular 
domains separated by two EGF-repeats and no G-domains at the C-terminal region [104, 105].  
The heterotrimer assembly of the a, b and g chains to a long-coiled arm is facilitated through 
disulfide-bonds at the C-terminal region and the centre, leaving the N-terminal regions of a, b 
and g chains free, resulting in three short arms (Figure 4) [104-106]. 
The assembly of higher-order laminin networks on the other hand, is facilitated by linking the 
N-terminal region of one a, b and g chain of three laminin heterotrimers, while the cell-
adhesion to transmembrane cell receptor, such as integrins, is facilitated through the G domain 
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of the C-terminal region, influencing the signalling cascade (see Figure 4 for laminin structure) 
[105].    
1.3.2.2 Type IV collagen 
Collagens are triple-helical proteins which consist of three a chains self-assembling into either 
homo- or heterotrimers [107]. The 28 currently recognized collagen types consist of repeated 
Gly-X-Y motifs, where X typically comprises proline and Y hydroxyproline [100, 107].  
Type IV collagen was first discovered in 1966 by Nicholas Kefalides while studying 
glomerular BM protein extracts of dogs [108]. It is a non-fibrillar collagen which, in contrast 
to fibrillar collagens such as type I, II, III, V, XI, XXIV and XXVII collagens, has the ability 
to self-assemble into networks[107]. Type IV exists in three different heterotrimer forms 
distinguished by the assembly of six different a chains (a1-a6), while the most common 
variant consists of two a1 and one a2 subunit. Each of the 400nm long a chains contain a triple 
helical domain, important for assembly and an N-terminal 7S domain as well as a C-terminal 
globular domain (NCI), important for network formation [105]. For the heterotrimer assembly 
of type IV collagen, NCI domains of three a chains interact, followed by zippering of the triple-
helical domains resulting in the formation of a promoter. Further for network-assembly, NCI 
domains of two promoters form dimers followed by cross-linking of 7S domains of four 
promoters to form a tetramer building up a network-structure which ultimately links to laminin 
networks through nidogen (see Figure 4 for type IV collagen structure) [95, 105].   
1.3.2.3 Nidogens and perlecans 
Nidogens are glycoproteins that come in two forms, N1 and N2, and consist of three globular 
domains which are separated by two rod-like segments. They mainly support BM assembly 
and stabilization by binding to the short arm of the laminin g chain as well as the triple-helical 
region of type IV collagen [105].  
Perlecans consist of five domains covalently-linked to three heparan sulfate proteoglycan 
molecules at the N-terminal region. While the heparan sulfate molecules serve as a growth 
factor reservoir the five core domains present binding sites for laminins and type IV collagen 
rendering perlecans a similar function to nidogens [104, 105]. 
1.3.2.4 Basement membrane assembly 
In vivo BM assembly starts with laminin-cell interactions in which the laminin G domains 
anchor to the cell surface through intergrins, a dystroglycan and sulfate glycolipids. As soon 
as sufficient laminin heterotrimers are anchored to the cell surface, the short arm of the a, b, g, 
chains bind to adjacent chains, forming ternary nodes. Once the laminin network has formed 
type IV collagen, perlecan, nidogen and argin assemble on the network allowing type IV 
collagen polymerization to a covalently stabilized second network. Nidogen binds type IV 
collagen, as well as the g subunit of laminin, connecting both networks while agrin and perlecan 
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primarily bind to the coiled-coil domain of laminin and to nidogen as well as cell surface 
receptors (see Figure 4 for BM assembly) [95]. 
 
Figure 4: Laminin and type IV collagen domain structure and their basement membrane assembly. Adapted from Hohenester 
and Yurchenco 2012 CC 3.0 by Landes Bioscience. 
1.3.2.5 Cell-extracellular matrix adhesion molecules 
Cell adhesion molecules are surface proteins which mediate both cell-ECM interactions, 
primarily via integrins, as well as cell-cell interactions, mainly via selectins, cadherins and 
immunoglobulin superfamily members. Integrins, which are the biggest class of cell-ECM 
adhesion molecules, are heterodimeric transmembrane molecules which comprise of both a 
chains, participating in ECM binding, and b chains. They not only physically connect cells to 
the ECM but most importantly initiate cell signalling cascades, resulting in cytoskeletal 
reorganization, cell growth, survival and differentiation, playing an important role in stem cell 
fate [100]. While b1 and b3 integrins are expressed on various cell types, and mostly mediate 
cell-ECM adhesion, b2 integrins are exclusively expressed on white blood cells where they 
primarily medicate cell-cell interactions [109]. 
Further, integrins, as well as dystroglycans, are the primary anchorages for laminins as well as 
collagens and bind in a Ca2+ or Mg2+ dependent manner [100, 110].   
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2 AIMS 
The aim of this thesis was to investigate the role of laminins in stemness of pluripotent stem 
cells and in the male testicular stem cell niche environment. 
The specific aims were: 
• To determine the role of laminin 521 in stemness stabilization between different human 
embryonic stem cell lines. 
• To assess the clinical relevance of laminin 521 Klinefelter syndrome derived human 
induced pluripotent stem cells. 
• To examine the basement membrane composition of the developing male gonad.  
• To investigate basement membrane changes during testicular explant culture and its 
effect on germ cell survival. 
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3 MATERIAL AND METHODS 
3.1 ETHICS 
3.1.1 Animal work 
Teratoma assays for hiPSCs were performed on severe combined immunodeficiency 
(SCID)/beige mice with the approval of Stockholm south ethical committee (Dnr. S14-15). 
3.1.2 Human samples 
Ethical approval for the derivation and differentiation of hESC lines was obtained from the 
Regional Human Ethics Committee in Stockholm (Dnr. 454/02). 
Skin tissue biopsies from healthy male donors (HM100 31 years, HM200 34 years) and 
azoospermia patients diagnosed with KS (KS100 31 years, KS200 34 years) were obtained 
with a written consent and with the approval of the Regional Human Ethics Committee (Dnr 
2013/1132-32) at the Reproduktionsmedicin at the Karolinska Hospital Huddinge. 
Human male first trimester gonadal tissue ranging from 5 to 10 wpc was collected from elective 
surgical abortions with maternal written informed consent. Midwives were responsible for 
informing patients (over 18 years of age and Swedish speaking). The Regional Human Ethics 
Committee, Stockholm, Sweden, approved the collection (Dnr. 2007/1477-31 with 
complementary permissions 2011/1101-32, 2013/564-32 and Dnr. 2013/457-31/4).  
Ethical approval for the use of additional human first and second trimester gonadal tissue 
ranging from 9 to 17 wpc was obtained from the South East Scotland Research Ethics 
Committee (reference number 18/NE/0290) and the NRES committee North East-Newcastle 
and North Tyneside 1 reference number LREC08/S1101/1). Women gave written informed 
consent. 
Ethical approval for the use of pre- and peripubertal testicular tissue was obtained from the 
ethical board of Karolinska Institutet and the Reginal Ethics Board in Stockholm (Dnr. 2013-
2129-31-3), the National Ethics Board of Iceland, Reykjavik (VSN 15-002) and the Ethics 
Board of the University of Helsinki (426/13/03/03/2015). 
Ethical approval for the use of adult testicular tissue was obtained from the East of Scotland 
Research Ethics service committee REC Reference number – 15/ES/0094) for the use of 
archived human testicular tissue from the Pathology Departments at the Western General 
Hospital in Edinburgh. 
.  
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3.2 CELL CULTURE 
3.2.1 Primary fibroblast derivation and culture  
After removing the dermis of skin biopsies from healthy male donors and azoospermia patients 
diagnosed with KS, tissue was cut into approximately 1 mm3 pieces and plated on FBS coated 
plates with human dermal fibroblast (HDF) medium consisting of Dulbeco’s Modified Eagle 
Medium (DMEM), 10% FBS and 0.5% penicillin-streptomycin (pen-strep). The resulting 
fibroblast cultures (f-HM1, f-HM2, f-KS1, and f-KS2) were passaged with 0.05% Trypsin.  
3.2.2 Human pluripotent stem cell culture  
3.2.2.1 Human embryonic stem cell culture 
For feeder derived hESC maintenance, hESCs were cultured on mitotically inactivated hFFs in 
knock-out DMEM containing 20% KSR, 0.5% pen-strep, 2mM L-GlutaMAX, 1% non-
essential amino acids, 0.5 mM 2-mercaptoethanol and 8 ng/ml of recombinant FGF2. Cell 
colonies were passaged mechanically with a scalpel at a four- to six-day interval.  
To enable hESC culture on LN521 or LN121-coated plates, LN521 or LN121 was slowly 
thawed at 4 °C and diluted to a final concentration of 10 µg/ml. Plates were then coated with 
either LN521 or LN121 overnight at 4 ºC followed by 37 ºC for one hour. hES cells colonies 
were moved from hFFs to laminin coated plates and cultured in NutriStem medium at 37 ºC in 
5% CO2 with a daily media change. Upon confluency, hESCs were passaged as single cells 
using TrypLE Select every five to seven days.  
To enable hESC culture on Matrigel, hESC-qualified Matrigel was slowly thawed overnight 
on ice at 4 ºC and diluted 1:84 in NutriStem. Plates were then coated with Matrigel at 37 ºC. 
hES cells colonies were moved from hFFs to Matrigel coated plates and cultured in NutriStem 
medium at 37 ºC in 5% CO2 with a daily media change. Upon confluency, hESCs were 
passaged as single cells using TrypLE Select every five to seven days.  
3.2.2.2 Reprograming of human induced pluripotent stem cells and subsequent culture 
For fibroblast reprogramming 6x105 cells were electroporated with 1 µg of each plasmid; 
pCXLE-hOCT3/4-shp53, pCXLE-hSK, and pCXLE-hUL, using the 100 µl tip Neon System 
with 1650 V, 30 ms and 1 pulse settings. Transfected cells were plated onto non-coated cell 
culture plates with HDF medium for six days in 5% CO2 at 37 °C. Cells were collected with 
0.25% Trypsin and plated onto LN521 or hESC-qualified Matrigel coated plates with a density 
of 5x103 cells/cm2 and transferred to low oxygen conditions (5% O2, 5% CO2) at 37 °C. The 
following day, HDF medium was replaced by NutriStem with subsequent medium changes 
every two to three days. Cell colonies were manually picked and transferred onto new LN521 
coated plates 23-40 days after transfection and maintained in NutriStem medium throughout 
culture. Upon confluency, hiPSCs were passaged as single cells using TrypLE Select. In total 
five hiPSC lines were derived (ips-HM1, ips-HM2, ips-KS1, ips-KS2 and ips-HF1) (see Figure 
5 for hiPSC reprogramming schema).  
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Figure 5: hiPSCs reprogramming, culture and analysis schema. Adapted from Panula et al. 2019 with permission from 
Oxford University Press. 
3.2.3 Human pluripotent stem cell differentiation 
Confluent hiPSCs were detached as small cell clumps and plated onto ultra-low adhesion plates 
with NutriStem medium without growth factors containing 10 µM ROCK-inhibitor Y-27632 
for the first 24 h with subsequent media changes every two to three days. After two weeks the 
formed embryoid bodies were plated for an additional two weeks onto LN521 coated glass 
chamber slides and after a total culture of four weeks, the cells were fixed with 4% 
paraformaldehyde (PFA).  
3.2.4 Prenatal tissue explant culture 
First trimester male gonadal tissue samples ranging from 6-9 wpc were cultured using a 
testicular explant culture system established by Sato and colleagues [85]. The whole gonad was 
cut into three pieces and each piece cultured on top of a 0.35% agarose block in an air-liquid 
interface. The tissue pieces were cultured in NutriStem with 10% KSR and 1% pen-strep for 
14 days with a media change at day 7 of culture. At day 14 of culture, tissues were fixed in 4% 
PFA and paraffin embedded. 
3.2.5 Pre-and peripubertal tissue explant culture 
Pre- and peripubertal testicular tissue samples from patients ranging from 1.6 to 13.4 years 
were cultured using above mentioned testicular explant culture system. Small tissue pieces 
were cultured on top of an 0.35% agarose block in an air-liquid interface. The tissue pieces 
were cultured in NutriStem with 10% KSR, 1% pen-strep and 10-7 M melatonin for 14 days 
with a media change at day 7 of culture. At day 7 and 14 of culture, tissues were fixed in 4% 
PFA and paraffin embedded. 
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3.3 TERATOMA ASSAY 
Confluent hiPSCs were detached as small cell clumps and plated onto ultra-low adhesion plates 
with NutriStem medium containing 10 µM ROCK-inhibitor Y-27632 for 24 hours. Sphere 
suspension was then mixed with hESC-qualified Matrigel and injected subcutaneously into 
SCID/beige mice with approximately 1x106 cells/injection. Mice were sacrificed and tumours 
collected three to eight weeks after injection. Tumours were fixed in 4% PFA and paraffin 
embedded cross-sections stained with Hematoxylin and Eosin.  
3.4 PROTEIN EXPRESSION 
3.4.1 Immunocytochemistry 
For hiPSC characterisation, cells were fixed with 4% PFA and permeabilized with 0.03% 
Triton X-100 in phosphate buffered saline (PBS). Cells were blocked in PBS containing 
donkey serum and bovine serum albumin (BSA) for 1 h and incubated with primary antibodies 
in blocking buffer at 4 °C overnight. After washing, cells were incubated with secondary 
antibodies in blocking buffer for 1 h at room temperature and counterstained with 1 µg/ml 
DAPI. hESC and hiPSCs were imaged with a confocal microscope (LSM700, Zeiss).  
3.4.2 Immunohistochemistry 
Paraffin embedded testicular tissue samples were cut into 5 µm thick sections, de-paraffinized 
and rehydrated in xylene and a descending ethanol series. Sections were subjected to heat-
mediated antigen retrieval at 95 ºC in either 10 mM sodium citrate or 10 mM Tris base and 1 
mM EDTA solution with 0.05% Tween 20 at a pH 9. Subsequently, samples were blocked with 
donkey serum and BSA before overnight incubation at 4 ºC with primary antibodies. Finally, 
samples were incubated with fluorescence conjugated secondary antibodies at room 
temperature before mounting with DAPI containing anti-fade mounting medium. 
3.4.3 Alkaline phosphatase 
For hiPSC colony counting in reprogramming conditions, cells were fixed with 4% PFA, 
washed with 0.05% Tween-20 in Tris-buffered saline and stained using an Alkaline 
Phosphatase (AP) Detection Kit. Positive colonies were counted and imaged with an Olympus 
IX81.  
3.5 CELL QUANTIFICATION 
Quantification of POU5F1, DDX4 and MAGE-A4 positive germ cells and evaluation of 
seminiferous cord area as well as round seminiferous tubule was performed each on one tissue 
section of the whole gonad as well as one tissue section of the cultured prenatal and pre- and 
peripubertal tissue cultures. Results are shown as mean ± standard deviation (SD).   
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3.6 DNA ANALYSIS 
3.6.1 Plasmid copy number 
For plasmid copy number analysis, genomic DNA was collected from hiPSCs using the 
DNeasy Blood and Tissue kit and analysed by quantitative PCR using SYBR Green. The 
pCXLE-EGFP plasmid and gDNA from a hESC line (H9) were used to generate standard 
curves to determine the plasmid or gene copy numbers from the threshold cycle (Ct) values. 
Primers for Epstein-Barr virus nuclear antigen 1 (EBNA-1) were used to detect plasmid copies 
and F-box protein 15 (FBXO15) primers were used as genomic copy number control.  
3.6.2 Karyotyping 
hiPSCs were treated with 10 µg/ml colcemid, collected with TrypLE Select and centrifuged. 
The cell pellet was resuspended in a 0.4% potassium chloride solution and incubated with 
methanol:acetic acid (3:1). Chromosomal G-band analysis was performed at the Genetics 
Clinic at Skåne University hospital, Sweden or at Karolinska University hospital, Sweden and 
at least 25 metaphases were analysed. 
3.6.3 FISH 
For single-molecule RNA FISH, fibroblasts and their respective hiPSCs were cultured on 
chamber slides, fixed with 4% PFA and permeabilized with methanol at -20°C. After air-drying 
the cells were incubated at 70 °C in Tris-EDTA buffer at a pH 8.0 and washed with saline-
sodium citrate buffer. Cells were hybridized with FISH probes for human XIST and human 
ATRX at 38.5 °C in hybridization buffer containing 10% deionized formamide, 10% dextran 
sulfate, 2 mg/ml tRNA from E. coli, 2 mM ribonucleoside vanadyl complex, 0.2 mg/ml BSA 
in saline-sodium citrate buffer. After washing cells with wash buffer containing 1 µg/ml 
Hoechst 33342 at 38.5 °C, cells were mounted with ProLong Diamond Antifade Mountant. 
Image stacks were acquired using Nikon Ti-E motorized inverted microscope. 
DNA FISH was performed on the same chamber slides. After removing the coverslips, cells 
were re-fixed with 4% PFA and dehydrated in ethanol followed by brief air-drying. Cells were 
treated with 100 µg/ml RNaseA at 37 °C followed by incubation with 10% pepsin in 0.01M 
HCl at 37 °C. Cells were then re-fixed with 1% PFA and dehydrated in ethanol and air-dried. 
Probe mixture consisting of Vysis CEP X (DXZ1) and Vysis CEP Y (DYZ1) probes and CEP 
hybridization buffer was applied onto slide with a coverslip and sealed with Fastik. Samples 
and probes were then co-denaturated at 85 °C followed by overnight hybridization at 41 °C in 
a humidity chamber. Slides were washed, cells counterstained with 1 µg/ml Hoechst 33342 and 
mounted with ProLong Diamond Antifade Mountant. Image stacks were acquired using Nikon 
Ti-E motorized inverted microscope.  
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3.7 GENE EXPRESSION 
3.7.1 qPCR 
For gene expression analysis, total RNA of three biological replicates of hESCs and three 
consecutive passages of fibroblasts and their respective hiPSCs was extracted using the RNeasy 
Mini Kit with on-column DNaseI treatment. Reverse transcription (RT) of RNA to cDNA was 
performed using iScript cDNA synthesis kit. Gene expression was quantified using TaqMan 
assays and StepOnePlus Real-Time PCR System. The relative quantity was determined with 
comparative Ct method (2-ΔΔCt), using GAPDH as an endogenous control and hESCs (HS980) 
or f-HF1 as reference sample for hiPSCs.  
To evaluate variations in genes expression among hESCs the coefficient of variation (CV) of 
each gene was obtained by calculating the ratio between the SD and the mean value of all the 
cell lines together. Based on the CV value, variation was classified into four groups: I) up to 
10%, II) 11–25%, III) 26–50%, and IV) more than 50%. 
3.7.2 RNA sequencing 
Total RNA was extracted using the RNeasy Mini Kit with on-column DNaseI treatment from 
three consecutive passages of fibroblasts and their respective hiPSCs. cDNA library 
preparation and sequencing were performed at the Science for Life Laboratory, Sweden. 
Briefly, libraries were made using Illumina TruSeq® Stranded mRNA with poly-A selection. A 
total of 2 pools were made from the 33 samples and each sample pool was sequenced on 2 
lanes using Illumina HiSeq 2500 with 2x125 setup.  Initial quality control of generated paired-
end reads was performed using the FastQC software.  
The reference index-based algorithm HISAT 2.1.0 was used to align reads with human 
reference genome (GRCh37). The resulting BAM files were examined by MultiQC (version 
1.0) and then used to estimate transcript abundance (FPKM; Fragments Per Kilobase of exon 
per Million fragments mapped) values using Cufflinks. Pearson Product-Moment Correlation 
coefficient was calculated to examine closeness among replicates and one replicate (f-HM100 
p8) was excluded due to low correlation. Quantified expression values (FPKM) were imported 
into R (version 3.4.3), and principal component analysis (PCA) was conducted with top 10k 
highly expressing genes. 
Cuffdiff v2.2.1 was used to identify differentially expressed genes. The transcripts with p 
value < 0.05 & fold change ≥ 1.5 were considered to be significantly expressed.  
Sample specific Single Nucleotide Polymorphisms (SNPs) for chromosome X were identified 
using ‘mpileup2snp’ subcommand of VarScan2 with p value 0.5. Only uniquely mapped reads 
were considered (k=1). SNP locations with ≥ 30 reads were considered in downstream 
analysis. Informative SNPs for each donor were obtained by combining SNPs with ≥ 5 
reads on minor allele in fibroblast replicates and in corresponding hiPSC replicates (f-
HM1/ips-HM1: 436, f-HM2/ips-HM2: 368, f-KS1/ips-KS1: 880, f-KS2/ips-KS2: 725, f-
HF1/ips-HF1: 920, HS980: 783). SNPs were considered bi-allelic/with variation when 20-
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80% of reads corresponded to reference allele, and mono-allelic/no variation when <20% 
or >80% of reads corresponded to reference allele. Further, only transcripts with all SNPs 
showing either bi-allelic or mono-allelic status in all replicates were considered 
informative. 
3.7.3 Foetal single-cell RNA sequencing data processing 
The single-cell RNA-seq data of human foetal germ cells (FGCs) and their gonadal niche cells  
were downloaded from https://github.com/zorrodong/germcell [111]. Only male samples 
(1,079 of 2,210 cells) were selected, and the expression values on transcripts per million (TPM) 
were normalized by log2 (TPM/10+1). A total of 17,633 genes with expression levels higher 
than 1 that were expressed in over 10 single cell samples were analysed using the R (version 
3.5.1) package Seurat (version 2.3.4) [112]. t-distributed stochastic neighbour embedding (t-
SNE) dimensionality reduction was carried out following the protocol of Li L et al. [111] in 
which male and female samples were analysed collectively. First, 360 highly variable genes 
with average expression greater than 2 and dispersion more than 2 were selected using the 
‘FindVariableGenes’ function and the scaled data were applied for PCA. Then, significant PCs 
were determined by the jackstraw procedure with 1,000 replicates. Here PC 1-12 were selected 
as significant (p < 1e-5), and t-SNE was performed using these PCs with ‘RunTSNE’ function. 
Finally, the resulting clusters were compared with Li L et al. [111], and annotated based on 
their classification. Even though those cells in the endothelial cell cluster were classified as 
outliers or into other clusters, 1,035 of 1,072 cells (96.5%) were consistently clustered. Gene 
expression overlays onto the t-SNE plots were performed using the ‘FeaturePlot’ function 
modified with ggplot2 (version 3.1.0). 
3.8 STATISTICAL ANALYSIS 
Statistical significance of reprograming efficiency was tested with unpaired t-test, n=3. 
Significance of pluripotency expression, XIST expression and total X chromosome expression 
for fibroblasts and their hiPSCs was assessed by one-way ANOVA using SigmaPlot 13.0 and 
significance accepted at p < 0.05.  
For prenatal germ cell quantification Kruskal-Wallis one-way ANOVA on Ranks was 
performed to confirm the statistical significance between first and second trimester germ cells 
quantity. For pre- and peripubertal germ cell quantification Kruskal-Wallis one-way ANOVA 
on Ranks and for laminin alpha 1 (LAMA1) quantification one-way ANOVA was performed 
to confirm the statistical significance between control and culture conditions. Analyses were 
performed with SigmaPlot 13.0 software and significance accepted at p < 0.05. 
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4 RESULTS AND DISCUSSION 
4.1 STABILIZING EFFECT OF LAMININ 521 ON HUMAN EMBRYONIC STEM 
CELLS (PAPER I)  
LN521 is expressed by and supports pluripotent cells of the ICM, thus it has been established 
as PSC culture substrate, especially for single-cell expansion culture. Although many studies 
have shown the positive effect on cell proliferation, as well as long term stem cell maintenance 
on LN521 substrates, we aimed to evaluate the effect of LN521 on gene expression profiles of 
hPSC. Therefore, we investigated the short-term effect of LN521 on gene expression profiles 
of five hFF derived hESC lines (HS360, HS364, HS380, HS401 and HS420) in comparison to 
traditional hFFs, as well as LN121 and Matrigel, as alternative culture substrates. 
4.1.1 Similar expression profile upon NutriStem vs. DMEM culture  
As the five hFF derived hESCs lines were originally cultured in growth factor containing 
DMEM medium and feeder-free culture adaption was planned with NutriStem growth factor 
containing medium, we wanted to exclude expression profile changes due to media variation 
first. Therefore, gene expression profiles of 17 pluripotency, stemness and gonadal genes 
(NANOG, GDF3, SOX2, POU5F1, NODAL, LEFTB, EBAF, TDGF1, KIT, UTF1, DDX4, 
SOX9, CYP11, SCF, SF1, StAR) were compared. As a similar expression pattern could be 
observed when comparing hFF derived hESCs cultured in either DMEM or NutriStem for four 
passages, we concluded a lack of media influence on our following experiments. 
4.1.2 Laminin 521 has superior cell support compared to laminin 121 and 
Matrigel 
In order to investigate the effect of various feeder-free culture substrates on hESC maintenance, 
two hESC lines (HS360 and HS380) were transferred from hFF to either LN521, LN121 or 
Matrigel coated plates for up to nine passages. Although hESC qualified Matrigel is often 
utilized for feeder-free PSC cultures, a higher incidence of cell differentiation and changes of 
stemness expression profile could be observed for Matrigel as well as LN121 cultures 
compared to LN521. Furthermore, LN521 showed superior support of cell adhesion and 
proliferation rate compared to LN121 and Matrigel, which became even more distinct with 
increased culture period. Although hESCs express LN521, LN121, LN511 and LN111 [113], 
poor cell survival of hESC was shown on LN121 and Matrigel in the absence of ROCK 
inhibitor [20]. As hPSC express α6β1 integrin, which has its highest binding affinity to 
laminin α5 chains [114], this could explain the inferior cell-adhesion capacities of LN121 
and Matrigel, which contain LN111, in comparison to LN521. Moreover, LN521-α6β1 
integrin interactions have been shown to induce the PI3K/Akt pathway, supporting self-
renewal and pluripotency expression [20, 115, 116]. 
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4.1.3 Laminin 521 homogenizes the pluripotency expression pattern of five 
human embryonic stem cell lines 
To analyse the effect of LN521 culture on hFF derived hESCs, all five hESC lines (HS360, 
HS364, HS380, HS401 and HS420) were transferred to LN521 and cultured for up to nine 
passages. Furthermore, variation in gene expression profiles between all five hESC lines was 
evaluated by comparison of the coefficient of variance, determined by the ratio of SD to mean 
expression value of all five cell lines. 
When comparing the gene expression profile of long term hFF cultured hESCs, a gene 
expression variation of more than 50% in 14 out of 17 genes could be observed between all 
five hESC lines, compared to 11 genes in early passage four LN521 cultures. The reduced gene 
expression variation in LN521 cultures became even more pronounced at passage nine, 
demonstrated by only seven out of 17 genes with more than 50% gene variation. Although, 
stemness genes such as NODAL, LEFTB, EBAF, TDGF1, UTF1, and LIN28 showed 
persistent gene expression variation of more than 50% when comparing passage four to nine, 
pluripotency genes such as NANOG, GDF3, POU5F1 and SOX2 showed a reduction in gene 
expression variation between all five hESC lines. Specifically, NANOG and GDF3 showed 
reduced variation from 54% and 66% to 34% and 28% respectively, POU5F1 and SOX2 from 
32% and 26% to 21% and 20% from passage four to passage nine, suggestive of a gene 
homogenizing effect of LN521 between different hESC lines.  
Although comparison of 59 hESC lines, from different derivation and maintenance techniques, 
from 17 different laboratories has revealed largely similar expression profiles, gene variations 
could be observed in POU5F1 and SOX2 [117]. Therefore, comparison of long-term LN521 
cultured hESC should be evaluated to explore further beneficial effects which could lead to 
less variability among different stem cell lines and more homogeneous results in in vitro 
differentiation experiments. 
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4.2 LAMININ 521 AND X CHROMOSOME INACTIVATION OF KLINEFELTER 
SYNDROME DERIVED HUMAN INDUCED PLURIPOTENT STEM CELLS 
(PAPER II) 
Since LN521 has shown beneficial pluripotency and cell adhesion effects on hFFs derived 
hESCs we further wanted to evaluate LN521 culture substrate for the reprogramming of healthy 
male (f-HM1, f-HM1) and female (f-HF-1), as well as KS dermal fibroblasts (f-KS1, f-KS2). 
Therefore, fibroblast cultures from skin biopsies and one commercially available female 
fibroblast line were established and transfection with episomal plasmids (pCXLE-356 
hOCT3/4-shp53, pCXLE-hSK and pCXLE-hUL) performed. 
4.2.1 Efficient derivation of human induced pluripotent stem cells on laminin 
521 
To investigate the reprogramming efficiency on LN521 or Matrigel, transfected fibroblasts 
were plated on respective plates 6 days after transfection and AP positive staining evaluated 
after 15 days of culture. Reprogramming efficiency was calculated, whereby LN521 cultures 
showed a significantly higher reprogramming efficiency than Matrigel cultures: 0.52% vs. 
0.36% (p < 0.05) respectively. Comparing this efficiency to the original report utilizing mouse 
feeder cells [118] with an efficiency of 0.39%, or laminin-511 E8 fragments with an efficiency 
of 0.077% [119], we could show the beneficial support of LN521 which is likely attributed to 
induction of pluripotency pathways of LN521-α6β1 integrin interactions [20, 115, 116].  
Nevertheless, in order to achieve high reprogramming efficiency, an optimal combination of 
culture substrate and reprogramming factors is required, as the use of LN521 in combination 
with lentiviral vectors could only achieve an efficiency of 0.3% [120].  
After 23 to 40 days post-transfection, reprogrammed cell colonies were manually picked and 
slowly adapted to single-cell enzymatic passaging on LN521 coated culture plates with loss of 
episomal plasmids confirmed at passage five in all five hiPSC lines (ips-HM1, ips-HM2, ips-
KS1, ips-KS2 and ips-HF1). In addition, cell lines with normal karyotype were cultured up to 
20 passages on LN521 coated plates and pluripotency protein and gene expression, as well as 
the potential for three germ layer formation in vivo and in vitro, confirmed. 
In line with hFF derived hESC cultures on LN521, no significant difference in pluripotency 
gene expression of POU5F1, NANOG, SOX2 and GDF3 could be observed in all five hiPSCs 
lines. 
4.2.2 X chromosome inactivation status of Klinefelter syndrome derived 
human induced pluripotent stem cells 
In order to investigate the XCI status of KS derived hiPSCs, three consecutive passages of KS 
dermal fibroblasts from two azoospermic men and their respective hiPSCs were evaluated. 
In alignment with the normal in vivo situation no XIST expression could be observed in f-HM1 
and f-HM2 while f-KS1 and f-KS2 showed similar expression profiles to f-HF1, indicating 
normal XCI. Furthermore, RNA FISH for XIST showed no cloud in both HM fibroblasts while 
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the presence of one XIST in around 90% of KS (f-KS1 88% and f-KS2 94%) and HF (f-HF 
95%) fibroblast could be observed, confirming normal XCI. Although a few KS and HF 
fibroblast showed the presence of two XIST clouds, DNA FISH of the same slides confirmed 
tetraploid cells which have shown to spontaneously occur in fibroblast cultures [121, 122]. 
Although XIST expression of KS derived hiPSCs (ips-KS1 and ips-KS2) and female hiPSCs 
(ips-HF1) showed no significant difference to f-HF1, H3K27me3 staining and XIST RNA FISH 
showed a variable XCI status. KS and female hiPSC lines displayed two cell populations 
showing either one H3K27me3 or XIST accumulation (XIST: ips-KS1 5%, ips-KS2 66%, ips-
HF1 6%) or no H3K27me3 or XIST accumulation (XIST: ips-KS1 95%, ips-KS2 34%, ips-HF1 
94%). As expected, male hiPSCs (ips-HM1 and ips-HM2) showed no H3K27me3 and XIST 
accumulation, while all hiPSCs displayed only a mono-allelic ATRX transcription site. 
When analysing transcriptomic data, similar levels of total X-linked gene expression (sum of 
FPKM values for X-linked genes) could be observed for one KS hiPSCs line (ips-KS2) 
compared to HM, HF and KS fibroblasts as well as HM hiPSCs. Interestingly, ips-KS1 and 
ips-HF1 showed significantly (p < 0.05) increased expression levels compared to HM and KS 
fibroblasts, HM hiPSCs and ips-KS2, indicating XCI erosion. 
Mono- or bi-allelic expression of X linked genes was additionally evaluated by analysing SNP 
variations of our RNA sequencing data against a reference genome. Based on bi-allelic 
observations in HM fibroblasts and hiPSCs (of those seven have a known Y homologue) 12 
unique transcripts were considered false positive and excluded. The majority of X-linked 
transcripts of ips-KS2 showed a mono-allelic (33) expression while six bi-allelic transcripts 
consisted of four known XCI escapee genes and two genes of unknown status. In contrast, ips-
KS1 and ips-HF1 showed a low number of mono-allelic transcripts (ips-KS1 25, ips-HF1 29) 
and a high number of bi-allelic transcripts (ips-KS1 50, ips-HF1 28) which included many 
known XCI inactive genes (ips-KS1 27, ips-HF1 14). As those results indicate an eroded XaXe 
XCI state for ips-KS1 and a normal XaXi XCI state for ips-KS2, DEG comparison to HM 
hiPSC was performed and revealed 24 X-linked genes out of 111 upregulated genes for ips-
KS2, while ips-KS1 showed 123 X-linked genes out of 192 upregulated genes, supporting the 
XaXe status of ips-KS1 and the XaXi status of ips-KS2.  
In alignment with previous studies showing various XCI states (either XaXa with both active 
X chromosomes, XaXi with one X chromosome inactive and covered by XIST or XaXe with 
loss of XIST and only partial persistence of inactivation) in long-term female hPSC cultures 
[123-126] our KS derived hiPSC lines display a similar behaviour to female hPSC. Although 
this phenomenon was mostly observed in studies applying MEF or Matrigel for hPSCs cultures, 
our LN521 cultures show similar behaviour, suggesting an independency of the applied culture 
substrate. Nevertheless, cultures under physiological oxygen conditions of 5% have shown to 
reduce X chromosome erosion [127] indicating a potential culture condition effect on this 
phenomenon. 
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4.3 COMPOSITION OF LAMININS IN THE DEVELOPING AND ADULT GONAD 
(PAPER III) 
Since LN521 has shown to play a crucial role in PSC self-renewal and pluripotency expression 
we wanted to evaluate the laminin expression profile of the testicular stem cell niche. 
Therefore, prenatal male gonads ranging from 5–17 wpc, pre- and peripubertal as well as adult 
testicular tissues were examined in regard to their BM composition. 
4.3.1 Prenatal basement membrane composition 
In order to investigate the BM composition immunofluorescence staining for all five a LN 
chains, fibronectin, as well as the type I, IV and VI collagens was performed. Depending on 
the developmental state of seminiferous cords, a net-like ECM structure of fibronectin, as well 
as type I, IV and VI collagens could be observed in 5 and 6 wpc gonads, in the absence of 
seminiferous cord formation. Upon presence of seminiferous cords, fibronectin, as well as type 
I, IV and VI collagens, could be observed in the BM of seminiferous cords of 5 wpc to 17 wpc 
gonads. Furthermore, the expression of all three collagen types could be observed throughout 
the interstitial compartment as well as blood vessels.  
Once seminiferous cords were formed, around 5-6 wpc, laminin a 1 (LAMA 1) expression 
could be observed as the sole LAMA chain in the seminiferous BM throughout all subsequent 
developmental stages examined. Interestingly, LAMA 5 could be observed from 7 wpc 
onwards in a few vascular BMs. In contrast LAMA 2, LAMA 3 and LAMA 4 were absent in 
the BM of both the seminiferous cords and the interstitial compartment with the exception of 
some occasional vasculature staining. Although vascular expression of LAMA 4 and 5 could 
be observed only in some vessels, variation of vascular laminin expression occurs based on the 
endothelial cell type, activation and vessel growth state, potentially explaining [128, 129] the 
expression of type IV collagen in all vessels compared to LAMA 4 and 5 in some vessels. 
Due to limited access to fresh male gonadal samples, published single-cell transcriptomic data 
from male prenatal gonadal germ and somatic cells was reanalysed to investigate the BM gene 
expression dynamics[111]. Based on the single-cell expression profile, 10 clusters could be 
identified in t-SNE analysis: Leydig cell precursors, differentiated Leydig cells, Sertoli cells, 
macrophages and early T cells, erythrocytes, migrating, mitotic as well as mitotic arrest FGCs, 
FGCs contaminated by haemocytes and outliers. Looking at the expression of Sertoli cells, 
which are in direct contact with the seminiferous BM, we could observe high expression of 
type IV collagen (COL4A1) and LAMA 1 and no or low expression of the remaining LAMA 
chains, as well as fibronectin (FN1) and type I (COL1A1) and VI collagens (COL6A1). Leydig 
cell precursors, situated in the interstitial compartment, showed expression of COL1A1 and 
COL6A1 while only low expression of COL4A1, LAMA 2 and LAMA 4 could be observed. In 
regards to germ cell clusters, all four clusters showed expression of COL4A1 as well as LAMA 
1, indicating that Sertoli and germ cells are contributing to the establishment of the 
seminiferous BM during prenatal life with the deposition of primarily LAMA 1 and type IV 
collagen.  
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Considering the structure of the mature adult testis, cell type specific prenatal gene expression 
patterns appear to be in alignment with the prospective adult BM organization, with Sertoli and 
germ cell expression of COL4A1 and LAMA 1 contributing to the deposition at the innermost 
lamina, and Leydig cells expression of COL1A1 and COL6A1, FN1, LAMA 2 and LAMA 4 
contributing to the deposition at the peritubular lamina as well as the vascular BM.  
4.3.2 Pre- and peripubertal basement membrane composition 
Since healthy pre-and peripubertal testicular tissue is difficult to obtain, analysis was performed 
on pre-and peripubertal tissue originating from the NORDFERTIL initiative for fertility 
preservation in male childhood cancer patients. For the evaluation of “normal” pre-and 
peripubertal BM composition samples of untreated and non-alkylating agents treated patients 
were evaluated. As those samples have been shown to have equivalent germ cell counts to a 
reported reference range and biobank controls [130], tissue samples of those pre- and 
peripubertal patient could be pooled, respectively. 
Similar to prenatal gonads, type IV collagen and fibronectin showed protein expression in the 
interstitial compartment as well as the seminiferous BM. Furthermore, LAMA 1 showed sole 
expression in the seminiferous BM while LAMA 5 was restricted to the vascular BM.  
4.3.3 Adult basement membrane composition 
For the evaluation of the established BM composition in adulthood, human adult testicular 
tissue from three individuals was evaluated. In contrast to prenatal and pre-and peripubertal 
samples, the adult testicular BMs showed more organization and compartmentalization of the 
seminiferous BM. Although all three collagen types could be observed, type I and VI collagen 
were expressed in the vascular BM as well as the collagenous and peritubular layer of the 
seminiferous BM, while type IV collagen was expressed in the vascular BM as well as the basal 
lamina and peritubular layer of the seminiferous BM. Fibronectin showed a similar expression 
to type I and VI collagen at the collagenous and peritubular layer of the seminiferous BM, as 
well as the vascular BM. 
Similar to prenatal, as well as pre- and peri-pubertal testicular samples, LAMA 1 showed sole 
expression in the seminiferous BM, with restriction to the basal lamina, while LAMA 5 
persisted in the vascular BM. In agreement with previous studies [131, 132]  no expression of 
LAMA 3 could be observed, however LAMA 2 and LAMA 4 expression was detected in the 
vascular BM, the interstitial compartment, as well as the peritubular layer of the seminiferous 
BM. In contrast to the broad seminiferous BM expression of LAMA 1, 2, 4 and 5 in mice [133], 
the human seminiferous BM appears more selective, with sole LAMA 1 expression throughout 
development and restriction to the innermost layer with direct contact to Sertoli cells and 
spermatogonia in adult testis, while LAMA 2 and 4 show peritubular expression, spatially 
separated to spermatogonia and Sertoli cell. 
Although no endothelial cluster could be identified in the prenatal single-cell transcriptomic 
data, the peritubular type I, IV and VI collagen, fibronectin and LAMA 2 and 4 protein 
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expression likely indicates the contribution of peritubular cells in interstitial and seminiferous 
BM deposition,  in line with mass spectrometry analysis of cultured adult human peritubular 
cells [74]. 
Interestingly, LAMA 2 showed further expression in early meiotic spermatocytes, while 
LAMA 4 could be observed as punctuate staining in spermatocytes. Disruption of Sertoli cell 
LAMA 2 expression has shown tight-junction perturbation in in vitro rodent experiments, 
accrediting blood-testis-barrier regulator effects to LAMA 2 [134-136]. As blood-barrier 
formation is initiated upon Sertoli cell maturation in puberty [47, 70] and no LAMA 2 
expression could be observed in prenatal as well as pre-and peripubertal samples, LAMA 2 
might play a critical blood-testis-barrier role in the adult human testis, similar to rodents. 
Nevertheless, further investigations are required to confirm the involvement and mechanism of 
LAMA 2 in the blood-testis-barrier. 
4.4 EFFECT OF LAMININ BASEMENT MEMBRANE DISRUPTION ON GERM 
CELL SURVIVAL 
In order to evaluate BM maintenance during gonadal and testicular organ culture, LAMA, type 
IV collagen and fibronectin protein expression was evaluated in prenatal as well as pre- and 
peripubertal samples after 14 days of tissue explant culture. Changes in germ cell expression 
patterns of POU5F1, DDX4 and MAGE-A4 were additionally evaluated in prenatal as well as 
pre- and peripubertal in vivo samples and compared to 14 days tissue explant cultures. 
4.4.1 In vivo germ cell expression profile  
In agreement with previous studies[137, 138], the presence of POU5F1, DDX4 and MAGE-
A4 positive germ cells could be observed from 5 wpc. As prenatal samples have not yet fully 
developed seminiferous tubules and thereby do not show round tubules in cross-sections, 
positive germ cells were evaluated from seminiferous cords and calculated per tubular surface 
area.  POU5F1 positive cells were present from 5 wpc (0.61 ±0.12 POU5F1+ve/mm2 of gonad 
area) with a peak at 9-10 wpc (1.12 ±0.83 POU5F1+ve/mm2 seminiferous cord area) and a 
steady decrease until 16-17 wpc (0.24 ±0.17 POU5F1+ve/mm2 seminiferous cord area). DDX4 
positive cells were observed from 5 wpc (0.56 ±0.14 DDX4+ve/mm2 of gonad area) with a peak 
at 9-10 wpc (1.38 ±1.27 DDX4+ve/mm2 seminiferous cord area) and a slight decrease until 16-
17 wpc (1.04 ±0.38 DDX4+ve/mm2 seminiferous cord area). On the contrary, only few MAGE-
A4 positive cells were expressed from 5 wpc (0.01 ±0.01 MAGE A4+ve/mm2 of gonad area) 
and steadily increased until 16-17 wpc (0.28 ±0.21 MAGE-A4+ve/mm2 seminiferous cord area).  
As no POU5F1 staining could be observed in pre- and peripubertal samples and MAGE-A4 
marks (pre) spermatogonia only DDX4 evaluation was performed for pre- and peripubertal 
tissue to cover a broad germ cell type range. As pre- and peripubertal samples already displayed 
round seminiferous tubules, positive germ cell numbers were calculated per round tubules (1.55 
±1.75 DDX4+ve/round seminiferous tubules). 
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4.4.2 Disruption of laminin expression during culture 
Although 14 day cultured prenatal male gonads were viable and showed a similar seminiferous 
BM profile, expressing LAMA 1, type I, IV and VI collagen and fibronectin similar to in vivo 
age-matched controls, LAMA 5 expression was additionally observed in the seminiferous BM, 
indicating poor cellular support of the applied culture conditions.   
Pre- and peripubertal cultures similarly showed seminiferous BM expression of type IV 
collagen and fibronectin with weak seminiferous LAMA 5 expression in a few samples. 
Surprisingly, pre- and peripubertal cultures showed a significant decrease of seminiferous 
LAMA 1 expression at day 7 and 14 of culture (D0 78.4% ±33.5 vs. D7 36.9% ±35.9 and D14 
15.5% ±28.5 LAMA 1+ve seminiferous tubules, p < 0.001). 
4.4.3 Germ cell loss during organ culture  
The presence of POU5F1, DDX4 and MAGE-A4 positive germ cells could be observed after 
14 days of organ culture in prenatal gonads similar to in vivo age-matched controls. Although 
a slight decrease in DDX4 and increase in MAGE-A4 could be observed compared to age-
matched in vivo controls further cultures are needed for proper comparison. 
In contrast, pre- and peripubertal testicular cultures showed a significant decrease in DDX4 
positive (D0 1.54 ±1.75 DDX4+ve/round seminiferous tubules vs. D14 0.31 ±0.62 
DDX4+ve/round seminiferous tubules; p < 0.001) germ cell counts with culture time with 
complete germ cell loss in most samples at day 14 of culture.  
Although prenatal gonadal cultures showed disruption of seminiferous BM expression with the 
additional presence of LAMA 5, the remaining expression of LAMA 1 as well as the lack of 
germ cell translocation to basal lamina at prenatal age could explain the minor effects on germ 
cell number. In contrast, the germ cell loss accompanied by the loss of LAMA 1 expression in 
pre- and peripubertal cultures, is indicative of the crucial role of LAMA 1 in germ cell 
signalling and maintenance and maintenance of the testicular stem cell niche homeostasis. 
Given collagen is capable of integrin interaction [100, 110] the significant germ cell loss upon 
LAMA 1 downregulation may not only be due to a loss of adhesion points but a result of 
disrupted LAMA 1-integrin mediated intracellular signalling as Sertoli cells still maintain 
within the seminiferous tubule. Furthermore, adverse effects of LAMA 1 loss on Sertoli cell 
signalling leading to disruption of germ cell maintenance cannot be excluded. 
Therefore, further investigations of LAMA 1-gem cell and LAMA 1-Sertoli cell interaction 
and signalling are needed to achieve a better understanding of the key role of LAMA 1 
homeostasis. 
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5 CONCLUSIONS 
In this thesis, we investigated the effects of laminins on stemness and maintenance of α6β1 
integrin expressing stem cells such as hESCs, hiPSCs and SSCs. Thus, the pluripotency of five 
hFF derived hESC lines was evaluated upon short-term LN521 culture. Furthermore, hiPSC 
reprogramming of KS fibroblasts was optimized using LN521 as culture substrate and XCI 
status compared to female hiPSCs. Finally, testicular laminin composition was evaluated 
during gonadal development and its importance for SSC maintenance evaluated. 
The main conclusions are listed below. 
 
• LN521 supports cell adhesion and hPSC maintanance of hFF derived hESCs in comparison 
to LN121 and Matrigel. 
• LN521 homogenizes pluripotency expression profiles between hESCs lines even during 
short-time culture and could therefore be used to homogenise stem cell populations for 
more reliable differentiation protocols.  
• LN521 in combination with NutriStem medium significantly improves reprogramming 
efficiency of hiPSCs using integration-free episomal plasmids and supports similar 
pluripotency behaviour. 
• KS derived hiPSCs display similar XCI characteristics to female hPSCs during culture, 
observed by either the maintenance of XCI with a XaXi state or erosion of XCI with XaXe 
state. In addition, LN521 culture suggests no beneficial effect on XCI maintenanace. 
• Although LN521 has shown to be a key component of the hPSC niche, LAMA 5 is only 
expressed in the vasculature of the developing and adult human testis. 
• LAMA 1 is the sole LAMA chain expressed in the seminiferous BM of prenatal as well as 
pre-and peripubertal testis. Furthermore, LAMA 1 is the sole LAMA chain located at the 
basal lamina of the adult seminiferous tubule with direct contact to Sertoli cells and SSCs.  
• Loss of testicular LAMA 1 expression, as observed following testicular explant culture, 
leads to germ cell loss suggesting LAMA 1  is a key component of the testicular stem cell 
niche. 
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